Robert O. Hopkins's most recent trade in DMK Pharmaceuticals Corp was a trade of 22,258 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 21, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DMK Pharmaceuticals Corp | Robert O. Hopkins | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2021 | 22,258 | 0 | - | - | Restricted Stock Units | |
| DMK Pharmaceuticals Corp | Robert O. Hopkins | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2021 | 22,258 | 277,067 (0%) | 0% | - | Common Stock | |
| DMK Pharmaceuticals Corp | Robert O. Hopkins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 20 Nov 2020 | 35,000 | 254,810 (0%) | 0% | 0.4 | 14,182 | Common Stock |
| DMK Pharmaceuticals Corp | Robert O. Hopkins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 18 Nov 2020 | 7,229 | 289,810 (0%) | 0% | 0.4 | 2,936 | Common Stock |
| DMK Pharmaceuticals Corp | Robert O. Hopkins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 29 Sep 2020 | 20,000 | 274,781 (0%) | 0% | 0.8 | 16,000 | Common Stock |